These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8653013)

  • 1. Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
    Wichmann MG; Haferlach T; Suttorp M; Zhang Y; Neppert J
    Infusionsther Transfusionsmed; 1996 Feb; 23(1):29-31. PubMed ID: 8653013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can blood group O red cells of donor origin acquire weak group A reactivity through serum A transferase of the recipient after bone marrow transplantation?
    Wichmann MG; Haferlach T; Suttorp M; Zhang Y; Neppert J
    Beitr Infusionsther Transfusionsmed; 1994; 32():146-8. PubMed ID: 9422108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of antibody to A- and B-transferases in minor incompatible bone marrow transplant.
    Barbolla L; Mojena M; Boscá L
    Br J Haematol; 1988 Dec; 70(4):471-6. PubMed ID: 3146341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABO serology in a case of persistent weak A in a recipient following a group O-matched unrelated bone marrow transplant.
    Grey DE; Fong EA; Cole C; Jensen J; Finlayson J
    Immunohematology; 2017 Sep; 33(3):99-104. PubMed ID: 29043826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically significant anti-A(1) in a presumed ABO-identical hematopoietic stem cell transplant recipient: a case report.
    Jaben EA; Jacob EK; Tauscher C; D'Souza A; Hogan WJ; Stubbs JR
    Transfusion; 2013 Jan; 53(1):202-5. PubMed ID: 22574682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.
    Lasky LC; Warkentin PI; Kersey JH; Ramsay NK; McGlave PB; McCullough J
    Transfusion; 1983; 23(4):277-85. PubMed ID: 6410549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO-incompatible allogeneic bone marrow transplant.
    López A; de la Rubia J; Arriaga F; Jiménez C; Sanz GF; Carpio N; Marty ML
    Transfusion; 1998 Mar; 38(3):247-51. PubMed ID: 9563404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic bone marrow transplantation across the ABO barrier.
    Biggs JC; Concannon AJ; Dodds AJ; Isbister JP; Kesteven P
    Med J Aust; 1979 Aug; 2(4):173-5. PubMed ID: 390333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A human dispermic chimaera first suspected from analyses of the blood group gene-specified glycosyltransferases.
    Watkins WM; Yates AD; Greenwell P; Bird GW; Gibson M; Roy TC; Wingham J; Loeb W
    J Immunogenet; 1981 Apr; 8(2):113-28. PubMed ID: 6785361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion.
    Blacklock HA; Gilmore MJ; Prentice HG; Hazlehurst GR; Evans JP; Ma DD; Knight CB; Hoffbrand AV
    Lancet; 1982 Nov; 2(8307):1061-4. PubMed ID: 6127543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABO blood group barrier in allogeneic bone marrow transplantation revisited.
    Seebach JD; Stussi G; Passweg JR; Loberiza FR; Gajewski JL; Keating A; Goerner M; Rowlings PA; Tiberghien P; Elfenbein GJ; Gale RP; van Rood JJ; Reddy V; Gluckman E; Bolwell BJ; Klumpp TR; Horowitz MM; Ringdén O; Barrett AJ;
    Biol Blood Marrow Transplant; 2005 Dec; 11(12):1006-13. PubMed ID: 16338623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow.
    Kominato Y; Fujikura T; Takizawa H; Hayashi K; Mori T; Matsue K; Yasue S; Matsuda T
    Exp Clin Immunogenet; 1990; 7(2):85-90. PubMed ID: 2108709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Method dependency of blood group determination after bone marrow transplantation.
    Wagner F; Wölpl A; Greher J; Kubanek B
    Beitr Infusionsther Transfusionsmed; 1994; 32():171-4. PubMed ID: 9422110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on serological blood group conversion rule and clinical blood transfusion in allogeneic hematopoietic stem cell transplantation].
    Yu ZQ; Gao ZF; Li HY
    Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):637-41. PubMed ID: 23134859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.
    Brady KA; Cowan MJ; Leavitt AD
    Transfusion; 1996 Apr; 36(4):314-7. PubMed ID: 8623130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological complications of a major ABO incompatible bone marrow transplantation in a Polynesian with aplastic anemia.
    Ockelford PA; Hill RS; Nelson L; Blacklock HA; Woodfield DG; Matthews JR
    Transfusion; 1982; 22(1):62-5. PubMed ID: 7039010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for leukemia and aplastic anemia: management of ABO incompatibility.
    Curtis JE; Messner HA
    Can Med Assoc J; 1982 Mar; 126(6):649-55. PubMed ID: 7039802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody to blood group glycosyltransferases, produced by hybrids constructed with Epstein-Barr-virus-transformed B lymphocytes from a patient with ABO-incompatible bone marrow transplant and mouse myeloma cells.
    Kominato Y; Fujikura T; Shimada I; Takizawa H; Hayashi K; Mori T; Matsuda T
    Vox Sang; 1990; 59(2):116-8. PubMed ID: 2173279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of anti-ABO blood group antibodies after minor ABO-incompatible bone marrow transplantation in NOD/SCID/gamma(c)(null) mice.
    Tomita H; Fuchimoto Y; Mori T; Kato J; Uemura T; Handa M; Tazawa H; Ohdan H; Okamoto S; Kuroda T
    Clin Transplant; 2013; 27(6):E702-8. PubMed ID: 24125194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.